Home » Topics » BioWorld Science

BioWorld Science
RSS

Galapagos initiates clinical trial with triple combination therapy in cystic fibrosis

April 25, 2018

Novartis offers overview of first quarter 2018

April 25, 2018

Celgene launches Istodax in Japan

April 24, 2018

Malaria vaccine R-21 shows efficacy in a phase IIa trial

April 24, 2018

FDA grants fast track designation to AAV-RPGR

April 24, 2018

Atozet launched in Japan

April 24, 2018

Novel selective estrogen receptor degrader LX-039 selected for clinical development

April 24, 2018

AstraZeneca reports data from ARCTIC study of Imfinzi and tremelimumab in third-line NSCLC

April 24, 2018

Researchers present potent EGFR T790M-mutant inhibitor E-191

April 24, 2018

FDA issues partial clinical hold for tazemetostat trials

April 24, 2018

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...